FR EA
1007-00006 · Vantage Mobility Systems Corp · Transaction Documents
disclosure-schedules-buyer-form.docx DOCUMENT M&A / Corporate
9 / 12 ← → ✕
Contract analysis Extract to table

DISCLOSURE SCHEDULES TO THE STOCK PURCHASE AGREEMENT

Buyer's Form — Template and Selected Schedules

Prepared in connection with the Stock Purchase Agreement (the "Agreement"), dated as of June 6, 2025, by and among:

VANTAGE MOBILITY SYSTEMS CORP. a Delaware corporation ("Buyer")

THE SELLING STOCKHOLDERS IDENTIFIED THEREIN

and

PULSELINK TELEMATICS, INC. a Delaware corporation (the "Company")

Prepared by:

Calderwood & Harkness LLP Buyer's Counsel

Matter Reference: 1001-00004

CONFIDENTIAL — ATTORNEY WORK PRODUCT

This document and the information contained herein are strictly confidential and are protected by the attorney-client privilege and/or the work product doctrine. This document is being furnished solely in connection with the transactions contemplated by the Agreement and may not be disclosed, copied, or distributed to any person without the prior written consent of Calderwood & Harkness LLP and Vantage Mobility Systems Corp.

Right-click to update Table of Contents

INTRODUCTORY NOTES AND INSTRUCTIONS

General Instructions for Completion of Disclosure Schedules

These Disclosure Schedules (collectively, the "Disclosure Schedules") are delivered pursuant to, and form an integral part of, the Stock Purchase Agreement, dated as of June 6, 2025 (the "Agreement"), by and among Vantage Mobility Systems Corp., a Delaware corporation ("Buyer"), the Selling Stockholders identified therein (collectively, the "Sellers" or the "Selling Stockholders"), and PulseLink Telematics, Inc., a Delaware corporation (the "Company"). The following general instructions and interpretive guidelines apply to the Disclosure Schedules in their entirety:

1. Correspondence to Agreement Sections. Each schedule contained herein corresponds to the section of the Agreement bearing the same number. For example, Schedule 3.3 corresponds to Section 3.3 of the Agreement. Where a schedule is designated with a part letter (e.g., Schedule 3.3, Part A), such designation is for organizational convenience and relates to the same section of the Agreement unless otherwise indicated.

2. Defined Terms. Capitalized terms used but not defined in the Disclosure Schedules shall have the respective meanings ascribed to them in the Agreement. In the event of any conflict between a defined term used in the Disclosure Schedules and the corresponding definition in the Agreement, the definition set forth in the Agreement shall control.

3. Cross-Disclosure. Information disclosed in any particular schedule shall be deemed disclosed with respect to all other schedules to which such information is relevant, to the extent the relevance of such disclosure to such other schedules is reasonably apparent on the face of such disclosure, without regard to whether a specific cross-reference to another schedule is made. The parties acknowledge that the practical organization of information across multiple schedules may result in information pertinent to one representation or warranty being set forth in a schedule that corresponds to a different representation or warranty.

4. No Admission of Materiality. The inclusion of any item, matter, event, or circumstance in a schedule does not constitute an admission by the Company, any Seller, or Buyer that such item, matter, event, or circumstance is material, constitutes or gives rise to a Material Adverse Effect (as defined in the Agreement), or is required to be disclosed under the Agreement. Thresholds of materiality, knowledge qualifications, and other limitations set forth in the representations and warranties of the Agreement continue to govern the scope and applicability of the disclosures made herein.

5. Qualification by Agreement. The Disclosure Schedules are qualified in their entirety by reference to the specific provisions of the Agreement, including the definitions, limitations, and exceptions set forth therein. Nothing in the Disclosure Schedules is intended to broaden the scope of any representation, warranty, covenant, or agreement contained in the Agreement.

6. Headings. The section and subsection headings contained in the Disclosure Schedules are included for convenience of reference only and shall not affect in any way the meaning or interpretation of the Disclosure Schedules or the Agreement.

7. Supplemental Disclosure Obligation. In accordance with the update and supplement provisions of the Agreement, the Company and the Sellers' Representative shall have the right, and where required by the Agreement shall have the obligation, to supplement or amend the Disclosure Schedules from time to time between the date of the Agreement and the Closing Date to reflect changes in facts or circumstances arising or discovered after the date hereof, subject to the terms and conditions of the Agreement governing such supplements and amendments.

8. Accuracy and Completeness. The Company and each Selling Stockholder are responsible for the accuracy and completeness of all information set forth in the Disclosure Schedules and shall certify the same pursuant to the Schedule Completion Certification attached hereto as Exhibit A.

Format and Conventions

The following formatting conventions apply throughout the Disclosure Schedules:

• Dollar Amounts. All dollar amounts set forth herein are expressed in United States dollars and are rounded to the nearest whole dollar, unless otherwise stated. Where an amount is preceded by a tilde (~) or the word "approximately," such amount is an estimate and is subject to final confirmation by the Company.

• Share Numbers. All share numbers are exact as reflected in the Company's stock transfer ledger maintained by the Company's corporate secretary, unless otherwise noted. Fractional shares, if any, are reported to the nearest whole share.

• Percentage Ownership. Percentage ownership of the Company's outstanding capital stock is calculated based on a total of 7,480,000 shares of common stock, par value $0.001 per share, issued and outstanding as of the date of the Agreement. Percentages are rounded to two decimal places.

• ACV. As used herein, "ACV" means approximate annual contract value, calculated on the basis of annualized revenue attributable to a particular customer contract during the most recently completed fiscal year or, with respect to contracts entered into during the current fiscal year, projected annualized revenue for the twelve-month period following execution.

• Contract Expiration Dates. All references to contract expiration or termination dates are as of the date hereof and do not give effect to any renewal, extension, or amendment that may occur after the date of the Agreement, unless otherwise specified.

• Brackets and Incomplete Items. Items designated with brackets (e.g., "[To be completed by the Company]") indicate information that is to be provided by the Company or the Selling Stockholders and has not yet been received by Buyer's counsel as of the date of preparation of this template. All bracketed items must be completed prior to execution of the Agreement or, where the Agreement so permits, prior to the Closing Date.

• Instruction Notes. Paragraphs beginning with "Instruction:" are internal drafting instructions from Buyer's counsel to the Company and its counsel and are not intended to constitute substantive disclosure. Such instruction paragraphs will be removed from the final executed version of the Disclosure Schedules.

SCHEDULE 1.1 — SELLING STOCKHOLDERS

Part A: Schedule of Selling Stockholders and Share Ownership

The following table sets forth the name, address, number of shares of Company common stock held, and percentage of outstanding shares of Company common stock owned by each Selling Stockholder as of the date of the Agreement. Percentage ownership is calculated based on 7,480,000 shares of common stock issued and outstanding.

Note: The aggregate amount of 1,198,000 shares designated as "Remaining Holders" above represents shares held by individual angel investors and current or former employees of the Company who received shares pursuant to early-stage equity grants or restricted stock purchase agreements. The Company shall provide a complete individualized list of all such holders, together with their respective addresses, share amounts, and original grant or acquisition dates, prior to execution of the Agreement. Each such holder shall be identified as a Selling Stockholder under the Agreement and shall be required to execute a joinder or counterpart signature page to the Agreement.

Part B: Sellers' Representative Designation

Pursuant to Article X of the Agreement, the Selling Stockholders have designated Graham Ellersick as the Sellers' Representative (the "Sellers' Representative"), authorized to act on behalf of all Selling Stockholders with respect to the following post-closing matters:

(a) All matters relating to the post-closing purchase price adjustment, including receipt and review of the final Closing Statement, negotiation with Buyer regarding any disputed items, and engagement and coordination with the Independent Accounting Firm;

(b) All matters relating to indemnification claims under Article IX of the Agreement, including receipt and response to indemnification notices from Buyer, negotiation and settlement of claims, and defense of contested claims;

(c) All matters relating to the Escrow Fund, including authorization of disbursements from the Escrow Fund and receipt of release instructions to the Escrow Agent;

(d) All matters relating to any amendment, waiver, or consent under the Agreement requiring the approval of the Selling Stockholders following the Closing;

(e) Receipt of any notices, correspondence, or communications from Buyer or its representatives on behalf of the Selling Stockholders; and

(f) Such other matters as are expressly delegated to the Sellers' Representative under the Agreement.

The Sellers' Representative shall have the authority to bind all Selling Stockholders in connection with the foregoing matters and shall be entitled to rely upon the Sellers' Representative Expense Fund (as defined in the Agreement) to defray costs, expenses, and liabilities incurred in connection with the performance of the Sellers' Representative's duties.

Part C: Stockholders Subject to Non-Competition and Non-Solicitation Obligations

In accordance with Section 7.8 of the Agreement, each Selling Stockholder holding five percent (5%) or more of the outstanding shares of Company common stock as of the date of the Agreement is required to execute and deliver at the Closing a Non-Competition and Non-Solicitation Agreement in the form attached to the Agreement as Exhibit D (each, a "Non-Competition Agreement"). The following Selling Stockholders are subject to this requirement:

The restrictive period under each Non-Competition Agreement shall be two (2) years following the Closing Date. The geographic scope, restricted activities, non-solicitation obligations, and other terms and conditions of each Non-Competition Agreement are as set forth in Exhibit D to the Agreement.

With respect to Clearwater Ventures II, L.P., the Non-Competition Agreement shall be executed on behalf of the fund by its general partner, Clearwater Ventures Management II, LLC, and the restrictive covenants shall apply to the fund, its general partner, and their respective affiliates, in each case solely to the extent set forth in the Non-Competition Agreement.

SCHEDULE 3.3 — CAPITALIZATION

Part A: Authorized Capital Stock

The Company's Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware (Delaware File Number 6174829) on March 14, 2018, and as in effect on the date hereof (the "Charter"), authorizes the following capital stock:

(a) Common Stock. 10,000,000 shares of common stock, par value $0.001 per share (the "Common Stock").

(b) Preferred Stock. No shares of preferred stock of any series or class are authorized under the Charter.

The Company has not adopted any amendment to the Charter since March 14, 2018, and no amendment to the Charter is currently contemplated, pending, or in process.

Part B: Issued and Outstanding Capital Stock

As of the date of the Agreement, the issued and outstanding capital stock of the Company consists of the following:

(a) Common Stock. 7,480,000 shares of Common Stock are issued and outstanding. All such shares have been duly authorized, are validly issued, fully paid, and nonassessable, and were issued in compliance with all applicable federal and state securities laws. No shares of Common Stock are held in the Company's treasury.

(b) Preferred Stock. No shares of preferred stock of any series or class are issued or outstanding.

A complete breakdown of the shares of Common Stock held by each stockholder is set forth in Schedule 1.1, Part A, which is incorporated herein by reference.

Part C: Options, Warrants, and Other Rights

Instruction: The Company shall disclose all outstanding options, warrants, convertible securities, stock appreciation rights, phantom stock rights, restricted stock units, profits interests, or any other rights, agreements, or commitments of any kind obligating the Company to issue, sell, or otherwise transfer, or to grant, extend, or enter into any right to acquire, any shares of capital stock or other equity interest in the Company, or any securities convertible into or exchangeable for such capital stock or equity interests.

As of the date of the Agreement, there are no outstanding options, warrants, convertible securities, stock appreciation rights, phantom stock rights, restricted stock units, profits interests, or other rights, agreements, arrangements, or commitments of any kind that obligate the Company to issue, sell, deliver, or otherwise transfer, or cause to be issued, sold, delivered, or otherwise transferred, any shares of capital stock or other equity interest in the Company, or any securities or instruments convertible into or exchangeable or exercisable for, or that represent the right to receive, any shares of capital stock or other equity interest in the Company.

Note: For the avoidance of doubt, the 1,198,000 shares referenced in Schedule 1.1, Part A, as held by angel investors and employees represent issued and outstanding shares of Common Stock and do not represent unexercised stock options, unvested restricted stock awards, or any other contingent or conditional equity rights. To the extent any such shares were originally issued pursuant to restricted stock purchase agreements or early exercise arrangements, all applicable vesting conditions have been satisfied and all applicable restrictions have lapsed prior to the date hereof, as confirmed by the Company. The Company does not maintain an equity incentive plan, stock option plan, employee stock purchase plan, or any similar plan as of the date of the Agreement.

Part D: Stock Transfer Restrictions

Instruction: The Company shall list any contractual restrictions on the transfer of Company stock, including rights of first refusal, co-sale agreements, tag-along and drag-along rights, voting agreements, stockholder agreements, investor rights agreements, lock-up arrangements, repurchase rights, or any other agreement or arrangement restricting the transfer, voting, or disposition of any shares of Company capital stock.

The Company shall provide a complete description of all existing contractual restrictions applicable to the transfer of shares of Common Stock, including, without limitation:

(i) Any right of first refusal or right of first offer in favor of the Company or any stockholder;

(ii) Any co-sale or tag-along rights;

(iii) Any drag-along rights;

(iv) Any voting agreement or voting trust;

(v) Any stockholder agreement, investor rights agreement, or registration rights agreement;

(vi) Any lock-up or standstill arrangement;

(vii) Any repurchase option or call right; and

(viii) Any other agreement, arrangement, or understanding restricting, conditioning, or governing the transfer, sale, pledge, encumbrance, or other disposition of any shares of Company capital stock.

To the extent any such agreements are in effect as of the date hereof, the Company shall provide complete copies of such agreements and shall identify any consents, waivers, or terminations required in connection with the transactions contemplated by the Agreement.

[To be completed by the Company.]

Part E: Stock Ledger Confirmation

Instruction: The Company shall attach a true, correct, and complete copy of the Company's stock transfer ledger (or equivalent record of stockholders of record) as of a date not more than five (5) business days prior to the date of the Agreement, certified by the Company's corporate secretary or an authorized officer.

The Company's stock transfer ledger has been maintained by the Company's corporate secretary at the Company's principal office. The Company's registered agent in the State of Delaware is:

Capitol Registered Agents, Inc. 1209 Orange Street Wilmington, Delaware 19801

The Company shall deliver the certified stock transfer ledger as an attachment to this Schedule 3.3, Part E, prior to execution of the Agreement.

SCHEDULE 3.5 — SUBSIDIARIES

Part A: List of Subsidiaries

The Company has one (1) direct wholly-owned subsidiary as set forth in the table below. The Company does not have any other subsidiaries, and neither the Company nor its subsidiary holds any equity interest, membership interest, partnership interest, joint venture interest, or other ownership interest in any other person or entity.

Part B: Subsidiary Details

Soluciones PulseLink de México, S. de R.L. de C.V. ("PulseLink Mexico")

PulseLink Mexico was organized under the laws of Mexico on August 22, 2019, and is duly organized, validly existing, and in good standing (or the Mexican equivalent thereof) under the laws of the United Mexican States. PulseLink Mexico is registered with the Registro Público de Comercio of the State of Jalisco and maintains its principal office at Av. Vallarta 6503, Piso 4, Col. Ciudad Granja, Zapopan, Jalisco 45010, Mexico.

PulseLink Mexico serves as the Company's dedicated engineering and software development center in Guadalajara, Mexico. PulseLink Mexico employs approximately twenty-eight (28) persons, consisting primarily of software engineers, firmware developers, quality assurance specialists, and administrative support staff. PulseLink Mexico does not engage in direct sales or marketing activities and does not maintain any independent customer relationships. All services performed by PulseLink Mexico are provided exclusively to PulseLink Telematics, Inc. under the terms of the intercompany Engineering Services Agreement referenced below.

PulseLink Mexico operates pursuant to an Intercompany Engineering Services Agreement with PulseLink Telematics, Inc., dated September 1, 2019, as amended (the "ESA"), which governs the provision of engineering, software development, testing, and related technical services by PulseLink Mexico to the Company. The ESA establishes a cost-plus transfer pricing methodology for intercompany charges. Additional details regarding the ESA are set forth in Schedule 3.14, Item 5.

Note: Buyer and the Company have agreed that the ESA will be reviewed and restructured following the Closing to align with Buyer's global transfer pricing policies and operational requirements. The restructuring is expected to include revisions to the scope of services, fee structure, intellectual property assignment provisions, and reporting obligations, as well as any modifications required to comply with applicable Mexican tax and labor regulations. The parties anticipate completing the restructuring within one hundred twenty (120) days following the Closing Date.

All equity interests in PulseLink Mexico are held directly by PulseLink Telematics, Inc., free and clear of all liens, encumbrances, security interests, pledges, claims, options, rights of first refusal, and restrictions, except as may be imposed by the organizational documents of PulseLink Mexico or applicable Mexican law.

SCHEDULE 3.7 — FINANCIAL STATEMENTS

Part A: Audited Financial Statements

Instruction: The Company shall attach complete copies of the audited financial statements of PulseLink Telematics, Inc. and its consolidated subsidiary for each of the following fiscal years, together with the report of the Company's independent auditor thereon:

(i) Fiscal year ended December 31, 2022 ("FY 2022");

(ii) Fiscal year ended December 31, 2023 ("FY 2023"); and

(iii) Fiscal year ended December 31, 2024 ("FY 2024").

The Company's independent auditor is Hargrove & Lindt CPAs LLP, located at 250 West Street, Suite 500, Columbus, OH 43215 (the "Auditor"). The Auditor has issued unqualified (clean) audit opinions on the Company's financial statements for each of FY 2022, FY 2023, and FY 2024.

The following summary financial information is provided for reference with respect to FY 2024:

Note: The foregoing summary is derived from management estimates and is subject to adjustment based on the final audited financial statements to be attached hereto. Adjusted EBITDA is a non-GAAP financial measure and excludes stock-based compensation, one-time transaction costs, and certain non-recurring items as agreed by the parties.

The audited financial statements, including the consolidated balance sheet, consolidated statement of operations, consolidated statement of stockholders' equity, and consolidated statement of cash flows for each of FY 2022, FY 2023, and FY 2024, together with all related notes and the Auditor's reports thereon, are to be attached hereto as Annex 3.7(A).

Part B: Interim Financial Statements

Instruction: The Company shall attach the most recent unaudited interim financial statements (monthly or quarterly) of the Company and its consolidated subsidiary available as of the date of the Agreement. At a minimum, such interim financial statements shall include an unaudited balance sheet and an unaudited statement of operations for the period from January 1, 2025 through the most recent month-end for which financial statements are available. Such interim financial statements shall be prepared in accordance with the Company's customary accounting practices, applied on a basis consistent with the audited financial statements, subject to normal year-end adjustments and the absence of footnote disclosures.

[To be provided by the Company.]

Part C: Working Capital

The parties have agreed to the following working capital provisions in connection with the post-closing purchase price adjustment under Section 2.4 of the Agreement:

Target Net Working Capital. The Target Net Working Capital (as defined in Section 2.4(a) of the Agreement) is $4,800,000.

Estimated Net Working Capital. Based on the Estimated Closing Statement to be delivered by the Company to Buyer no later than three (3) business days prior to the anticipated Closing Date in accordance with Section 2.4(b) of the Agreement, the Company estimates that the Net Working Capital of the Company as of the close of business on the day immediately preceding the Closing Date will be approximately $5,040,000.

Estimated NWC Excess. Based on the foregoing, the estimated excess of Estimated Net Working Capital over Target Net Working Capital is $240,000 ($5,040,000 minus $4,800,000). In accordance with Section 2.4(c) of the Agreement, this estimated excess will be added to the Purchase Price at the Closing, subject to the post-closing true-up described below.

Post-Closing True-Up Procedures. The post-closing purchase price adjustment shall be conducted in accordance with the following timeline:

(a) Closing Statement Delivery. Within ninety (90) days following the Closing Date, Buyer shall prepare and deliver to the Sellers' Representative a final Closing Statement setting forth Buyer's determination of the actual Net Working Capital of the Company as of the close of business on the day immediately preceding the Closing Date, together with reasonable supporting documentation.

(b) Review Period. The Sellers' Representative shall have thirty (30) days following receipt of the Closing Statement (the "Review Period") to review the Closing Statement and deliver to Buyer a written notice of disagreement specifying each item in dispute and the Sellers' Representative's determination of the correct amount for each such item. If the Sellers' Representative does not deliver a notice of disagreement within the Review Period, the Closing Statement as delivered by Buyer shall be deemed final and binding on the parties.

(c) Negotiation Period. If a notice of disagreement is timely delivered, Buyer and the Sellers' Representative shall negotiate in good faith for a period of thirty (30) days to resolve any disputed items. Any items not disputed shall be deemed final and binding.

(d) Independent Accounting Firm. Any disputed items remaining unresolved at the end of the negotiation period shall be submitted for resolution to Calloway Price & Associates LLP, located at 221 North LaSalle Street, Suite 1600, Chicago, IL 60601 (the "Independent Accounting Firm"). The Independent Accounting Firm shall act as an expert, not an arbitrator, and shall determine only the disputed items in accordance with the definitions and methodologies set forth in the Agreement. The determination of the Independent Accounting Firm shall be final and binding on the parties absent manifest error. The fees and expenses of the Independent Accounting Firm shall be allocated between the parties in proportion to the extent to which each party's position was not accepted by the Independent Accounting Firm.

SCHEDULE 3.10 — REAL PROPERTY

Part A: Owned Real Property

Instruction: The Company shall list all real property owned in fee simple, or in which the Company or any Subsidiary holds any other ownership interest (including ground leases, easements, or other real property interests), together with a description of the interest held and the current fair market value or book value of such property.

As of the date of the Agreement, neither the Company nor any Subsidiary owns any real property. The Company does not hold any fee simple interest, leasehold interest constituting owned real property, ground lease interest, or other ownership interest in any real property, except for the leasehold interests described in Parts B and C below.

Part B: Leased Real Property

The following table sets forth the material terms of the real property lease to which the Company is a party as a lessee:

Note: Buyer's counsel has requested a complete copy of the lease (including all amendments, addenda, estoppel certificates, and subordination, non-disturbance, and attornment agreements, if any) for review. The Company is expected to deliver such documentation promptly.

Part C: Mexican Subsidiary Premises

Instruction: The Company shall provide details of all real property leased, subleased, licensed, or otherwise used or occupied by Soluciones PulseLink de México, S. de R.L. de C.V., including the identity of the landlord or licensor, address of the premises, material lease terms, monthly or annual rent, lease expiration date, and any change-of-control or assignment provisions.

PulseLink Mexico maintains its engineering center at the following location:

Address: Av. Vallarta 6503, Piso 4, Col. Ciudad Granja, Zapopan, Jalisco 45010, Mexico

Complete lease details, including the identity of the landlord, lease commencement and expiration dates, monthly rent, square footage, permitted use, and any change-of-control or assignment provisions, are to be provided by the Company. The Company shall deliver a complete copy of the lease agreement (and any translations thereof) to Buyer's counsel for review.

[Lease details to be provided by the Company.]

SCHEDULE 3.12 — INTELLECTUAL PROPERTY

Part A: Patents

The following table sets forth all patents and patent applications owned by the Company or any Subsidiary as of the date of the Agreement:

Summary: The Company's patent portfolio consists of four (4) issued U.S. utility patents and two (2) pending U.S. patent applications. The Company does not hold any foreign patents or patent applications, any design patents, or any provisional patent applications as of the date hereof.

Instruction: The Company shall provide the following information for each patent and patent application: (i) patent or application number; (ii) filing date; (iii) issue date (if applicable); (iv) title; (v) named inventors; (vi) current assignee of record at the United States Patent and Trademark Office; (vii) any licenses, assignments, or encumbrances affecting such patent or application; and (viii) next maintenance fee due date (for issued patents). The Company shall also confirm that all maintenance fees, annuities, and renewal fees for issued patents are current as of the date hereof.

Part B: Trademarks

The following table sets forth the registered trademarks owned by the Company or any Subsidiary as of the date of the Agreement:

Summary: The Company's trademark portfolio consists of twelve (12) registered U.S. trademarks. The Company shall provide complete details for all twelve marks, including the two identified above and the ten additional marks to be listed.

Instruction: The Company shall provide the following information for each registered trademark: (i) the mark as registered (word mark, design mark, or combined mark); (ii) U.S. registration number; (iii) registration date; (iv) next renewal date; (v) international class(es); (vi) description of goods and/or services; (vii) current status (active, pending renewal, Section 8/Section 15 affidavits filed, etc.); and (viii) any licenses, security interests, or other encumbrances affecting such registration. The Company shall also disclose any pending trademark applications, common law trademark rights, and any opposition or cancellation proceedings.

Part C: Domain Names

The Company's primary domain name is:

www.pulselinktelematics.com

Instruction: The Company shall provide a complete list of all domain names owned, registered, or controlled by the Company or any Subsidiary, including the registrar, registration date, expiration date, and administrative and technical contact information for each domain name. The Company shall also identify any domain names that are subject to pending UDRP or other domain name dispute proceedings.

[To be completed by the Company.]

Part D: Copyrights and Software

The following proprietary software and copyrightable works have been identified as material intellectual property assets of the Company:

(a) PulseCore® TCU Embedded Firmware. Proprietary embedded firmware developed by the Company for the PulseCore® telematics control unit, including the real-time operating system kernel, sensor integration layer, cellular/GNSS communication stack, and over-the-air (OTA) update module. The firmware is written primarily in C and C++ and is deployed on ARM-based microcontroller platforms.

(b) FleetIQ® Analytics Platform SaaS Codebase. Proprietary software-as-a-service platform for fleet management analytics, consisting of the cloud-hosted back-end services (including data ingestion, processing, and storage pipelines), the web-based front-end dashboard application, and the companion mobile application (iOS and Android). The platform is built primarily on Python, TypeScript/React, and PostgreSQL.

(c) V2X Data Bridge Module Software. Proprietary software module enabling vehicle-to-everything (V2X) data exchange, supporting DSRC and C-V2X communication protocols. The module facilitates secure data sharing between PulseCore®-equipped vehicles and roadside infrastructure, traffic management systems, and third-party connected vehicle platforms.

Instruction: The Company shall confirm that no identified open-source license contamination has been detected as part of the intellectual property due diligence review, including with respect to copyleft licenses (e.g., GPL v2, GPL v3, AGPL, LGPL) that could require the Company to disclose, distribute, or license any proprietary source code.

Instruction: The Company shall provide a complete schedule of all open-source software components incorporated in or distributed with the Company's products and services, including for each component: (i) the name and version of the open-source component; (ii) the applicable open-source license type (e.g., MIT, Apache 2.0, BSD 2-Clause, GPL v2, LGPL, etc.); (iii) the manner in which the component is used (statically linked, dynamically linked, standalone, modified, etc.); and (iv) confirmation as to whether the applicable license terms have been complied with in all material respects.

[To be completed by the Company.]

Part E: IP Licenses and Encumbrances

Instruction: The Company shall list all licenses granted by the Company to any third party with respect to any intellectual property of the Company, and all licenses granted to the Company by any third party with respect to intellectual property of such third party (other than off-the-shelf, commercially available software licensed on standard terms). The Company shall also disclose any liens, security interests, pledges, encumbrances, or other restrictions on the Company's intellectual property assets.

[To be completed by the Company.]

SCHEDULE 3.14 — MATERIAL CONTRACTS

Introduction

Instruction: The Company shall list all Material Contracts (as defined in Section 1.1 of the Agreement) to which the Company or any Subsidiary is a party or by which any of their respective assets are bound, including all contracts, agreements, instruments, leases, licenses, commitments, undertakings, arrangements, and understandings, whether written or oral, that satisfy any of the criteria set forth in the definition of "Material Contract" in the Agreement. Without limiting the foregoing, the Company shall specifically identify any contract that: (i) involves aggregate payments or receipts in excess of $250,000 per year; (ii) is not terminable by the Company on less than ninety (90) days' notice without penalty; (iii) contains exclusivity, most-favored-nation, minimum purchase, or non-compete provisions; (iv) involves a government entity; (v) constitutes a joint venture, partnership, or strategic alliance agreement; (vi) involves guaranty, indemnification, or suretyship obligations in excess of $100,000; or (vii) is otherwise material to the business, operations, financial condition, or results of operations of the Company and its Subsidiary, taken as a whole.

List of Material Contracts

Item 1: Supply Agreement — Meridian Automotive Group, Inc.

The Meridian Automotive Group, Inc. relationship represents the Company's largest customer by revenue, accounting for approximately 29.3% of total FY 2024 revenue.

Item 2: Supply Agreement — Trident Motor Corporation

The Trident Motor Corporation relationship represents the Company's second-largest customer by revenue, accounting for approximately 20.6% of total FY 2024 revenue. The initial term of this Supply Agreement is scheduled to expire on June 30, 2026. Buyer's counsel notes that renewal discussions should be initiated promptly following the Closing to ensure continuity of this material customer relationship.

Item 3: Software Licensing & Services Agreement — Cascade Fleet Solutions LLC

Cascade Fleet Solutions LLC operates one of the largest independent fleet management networks in the Pacific Northwest and represents a strategically significant SaaS customer for the Company's FleetIQ® platform.

Item 4: Lease Agreement — Dublin, OH Office

Additional details regarding this lease are set forth in Schedule 3.10, Part B.

Item 5: Engineering Services Agreement — PulseLink Mexico (Intercompany)

Additional Material Contracts

Instruction: The Company shall identify any additional contracts meeting the definition of "Material Contract" under the Agreement. Without limiting the generality of the foregoing, the Company shall specifically review and disclose:

(a) Any contract involving aggregate annual payments or receipts in excess of $250,000;

(b) Any contract not terminable by the Company without penalty on less than ninety (90) days' prior written notice;

(c) Any contract containing exclusivity, most-favored-nation, or minimum purchase obligations;

(d) Any contract containing non-compete or non-solicitation restrictions binding on the Company or any Subsidiary;

(e) Any government contract or subcontract (federal, state, local, or foreign);

(f) Any joint venture, partnership, or strategic alliance agreement;

(g) Any agreement involving guaranty, suretyship, or indemnification obligations in excess of $100,000;

(h) Any distribution, reseller, or channel partner agreement;

(i) Any agreement relating to the acquisition or disposition of any business, assets, or equity interests;

(j) Any agreement relating to indebtedness for borrowed money, including credit facilities, notes payable, capital leases, and guarantees thereof;

(k) Any settlement agreement or consent decree involving continuing obligations;

(l) Any contract with any director, officer, or stockholder of the Company (other than the employment agreements and offer letters to be disclosed in Schedule 3.15); and

(m) Any other contract that is material to the business, operations, financial condition, or results of operations of the Company and its Subsidiary, taken as a whole.

[To be completed by the Company.]

SCHEDULE 3.15 — EMPLOYEES AND EMPLOYEE BENEFIT MATTERS

Part A: Key Employees

The following table sets forth information regarding the key employees of the Company and the post-closing employment or retention arrangements that have been negotiated in connection with the transactions contemplated by the Agreement:

Each of the foregoing key employees has entered into, or will enter into at the Closing, the applicable employment or retention agreement described above, in form and substance satisfactory to Buyer. Each key employee is also subject to the Non-Competition and Non-Solicitation Agreement described in Schedule 1.1, Part C.

Part B: Employee Census Summary

As of the date of the Agreement, the Company and its Subsidiary employ a total of approximately one hundred thirty-seven (137) persons, distributed across the following locations:

Instruction: The Company shall provide a complete employee census as of a date not more than five (5) business days prior to the date of the Agreement, including, for each employee: (i) full legal name; (ii) title and department; (iii) hire date; (iv) annual base compensation (salary or hourly rate); (v) target bonus or commission, if any; (vi) employment status (full-time, part-time, or temporary); (vii) work location (office, remote, or hybrid); (viii) exempt or non-exempt classification under the Fair Labor Standards Act (for U.S. employees); and (ix) visa or work authorization status (for non-U.S. citizen employees and employees of PulseLink Mexico). The employee census shall be delivered as a confidential supplement to this Schedule 3.15.

Part C: Employee Benefit Plans

Instruction: The Company shall list all "employee benefit plans" (as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended) and all other benefit plans, programs, policies, agreements, or arrangements maintained, contributed to, or required to be contributed to by the Company or any Subsidiary for the benefit of any current or former employee, officer, director, or independent contractor of the Company or any Subsidiary, or with respect to which the Company or any Subsidiary has any liability (contingent or otherwise). Without limiting the foregoing, the Company shall specifically identify:

(a) Group health insurance plans (medical, dental, vision);

(b) Life insurance and accidental death and dismemberment (AD&D) plans;

(c) Short-term and long-term disability plans;

(d) Retirement plans, including any 401(k) plan or similar defined contribution plan, and any defined benefit pension plan;

(e) Equity incentive plans, stock option plans, restricted stock plans, stock appreciation rights plans, and phantom equity plans;

(f) Annual bonus, incentive compensation, and commission programs;

(g) Severance plans, policies, or individual severance agreements;

(h) Change-of-control or transaction bonus arrangements;